TraceLink Earns Top-Tier ISO, SOC, and CyberVadis Results, Confirming Its Position as the Most Trusted Agentic Orchestration Platform for Life Sciences
Independent audits and a Platinum CyberVadis rating demonstrate the rigor, resilience, and maturity of the OPUS platform—the industry's secure, audit-ready foundation for digitalization, partner interoperability, and agentic orchestration TraceLink...
THIRDREALITY Showcases 2026 Product Roadmap and New Smart Devices at CES 2026
LAS VEGAS, Dec. 30, 2025 /PRNewswire/ -- THIRDREALITY, a smart technology brand focused on open standards and local-first intelligence, will participate in CES 2026 to present its 2026 product roadmap, highlighting a new generation of smart sensing...
International Digital Image Index 2025 Unveiled, Spotlighting China's Top Cities in Cyberspace
BEIJING, Dec. 30, 2025 /PRNewswire/ -- On December 28, 2025, The School of Journalism and Communication at Renmin University of China (RUC) and School of Journalism and Communication Chongqing University jointly released the International Digital...
Voniko Celebrates CES 2026 with Monthly Battery-Powered Device Giveaways
Colorado-based premium battery brand launches monthly Facebook giveaways to thank customers who powered their rise to Amazon's Top 4 BRIGHTON, Colo., Dec. 30, 2025 /PRNewswire/ -- Voniko®, the U.S.-based battery brand known for great value household...
World Customs Organization praises 'e-commerce platform' in trilingual report
Dubai: Global platform for digital commerce and new economy DUBAI, UAE, Dec. 30, 2025 /PRNewswire/ -- A new milestone reflecting Dubai's global leadership in customs innovation, Dubai Customs' innovative cross-border e-commerce platform has received...
Epicka to Debut World's First 140W Touchscreen Smart Universal Travel Adapter at CES 2026
LAS VEGAS, Dec. 30, 2025 /PRNewswire/ -- Epicka, a leading innovator in global charging solutions and among the top universal travel adapter brands in the U.S., announced it will participate in CES 2026 and present its new Pulse Duo series, a...
Mabwell Announces First Patient Dosed in Phase II Trial of Anti-IL-11 Antibody for Pathological Scarring
SHANGHAI, Dec. 30, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the Phase II clinical trial of its self-developed innovative anti-IL-11 monoclonal...
NYSE Content Advisory: Pre-Market Update + Wall Street Awaits Fed Minutes after latest Rate Cut
NEW YORK, Dec. 30, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content...